Adam S. Whalley, PharmD
Adam S. Whalley, PharmD is a PGY-1 pharmacy resident at UConn John Dempsey Hospital at UConn Health, Farmington, CT
Daclizumab approved for relapsing forms of multiple sclerosis
Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.

Poll